IMMP
Price
$0.45
Change
+$0.03 (+7.14%)
Updated
Jul 13 closing price
Capitalization
56.89M
50 days until earnings call
Intraday BUY SELL Signals
RADX
Price
$4.33
Change
-$0.04 (-0.92%)
Updated
Jul 13 closing price
Capitalization
32.6M
73 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMMP vs RADX

IMMP vs RADX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMMP vs. RADX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMP is a StrongBuy and RADX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (IMMP: $0.45 vs. RADX: $4.37)
Brand notoriety: IMMP and RADX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMP: 45% vs. RADX: 22%
Market capitalization -- IMMP: $56.89M vs. RADX: $32.6M
IMMP [@Biotechnology] is valued at $56.89M. RADX’s [@Biotechnology] market capitalization is $32.6M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMP’s FA Score shows that 1 FA rating(s) are green whileRADX’s FA Score has 1 green FA rating(s).

  • IMMP’s FA Score: 1 green, 4 red.
  • RADX’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMMP and RADX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMP’s TA Score shows that 7 TA indicator(s) are bullish while RADX’s TA Score has 5 bullish TA indicator(s).

  • IMMP’s TA Score: 7 bullish, 3 bearish.
  • RADX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, IMMP is a better buy in the short-term than RADX.

Price Growth

IMMP (@Biotechnology) experienced а +1.83% price change this week, while RADX (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

IMMP is expected to report earnings on Sep 02, 2026.

RADX is expected to report earnings on Sep 24, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMP($56.9M) has a higher market cap than RADX($32.6M). RADX YTD gains are higher at: -17.050 vs. IMMP (-84.248). RADX (-42.33M) and IMMP (-43.83M) have comparable annual earnings (EBITDA) . IMMP has more cash in the bank: 159M vs. RADX (36.4M). RADX has higher revenues than IMMP: RADX (1.68M) vs IMMP (0).
IMMPRADXIMMP / RADX
Capitalization56.9M32.6M175%
EBITDA-43.83M-42.33M104%
Gain YTD-84.248-17.050494%
P/E RatioN/AN/A-
Revenue01.68M-
Total Cash159M36.4M437%
Total Debt1.69MN/A-
FUNDAMENTALS RATINGS
IMMP: Fundamental Ratings
IMMP
OUTLOOK RATING
1..100
34
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMMPRADX
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 4 days ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 4 days ago
84%
Advances
ODDS (%)
Bullish Trend 21 days ago
84%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 4 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
IMMP
Daily Signal:
Gain/Loss:
RADX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VCRQX16.200.08
+0.50%
NYLI CBRE Global Infrastructure Class R6
ITHSX60.72N/A
N/A
Hartford Capital Appreciation R4
AQGNX13.50N/A
N/A
AQR Global Fund N
RALIX11.58N/A
N/A
Lazard Real Assets Instl
AIGGX15.86N/A
N/A
Aristotle Growth Equity I-2

RADX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RADX has been loosely correlated with ARTV. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RADX jumps, then ARTV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RADX
1D Price
Change %
RADX100%
-0.92%
ARTV - RADX
44%
Loosely correlated
-7.37%
CVKD - RADX
31%
Poorly correlated
-16.26%
FBIOP - RADX
29%
Poorly correlated
+1.05%
IMMP - RADX
26%
Poorly correlated
+7.52%
KYNB - RADX
23%
Poorly correlated
-3.42%
More